Pfizer

Pfizer (PFE) Net Profit And Net Margin From 2012 To 2016

This report provides the last five years net profit and net margin of Pfizer Inc (PFE) from 2012 to 2016. Pfizer reported a total net income of $7.2 billion during 2016. Pfizer generated a total of $52.8 billion revenues during 2016. Pfizer net profit margin was 13.7% during 2016. The net profit and the net profit margin correspond to the fiscal year ending in December.

Pfizer (PFE) Research & Development (R&D) Spending Analysis From 2012 To 2016

This report provides the last five years research and development (R&D) expenses of Pfizer Inc (PFE) from 2012 to 2016. Pfizer spent a total of $7.9 billion on research and development (R&D) activities during 2016. Pfizer generated a total of $52.8 billion revenues during 2016. As a percentage of revenues, Pfizer spent 14.9% of its total revenues on R&D activities during 2016. The R&D spending numbers are for the fiscal year ending in December.

Pfizer (PFE) Business Analysis – Analyze Historical Performance, Strategic Priorities, And Business Improvement Opportunities...

Pfizer Inc with $53 billion revenues in the year 2016 was the number 2 Pharmaceuticals company. Read this report to know the top competitors of Pfizer and identify growth and cost optimization opportunities of Pfizer

Pfizer (PFE) Revenues And Revenue Growth From 2012 To 2016

This report provides the last five years revenues and revenue growth of Pfizer Inc (PFE) from 2012 to 2016. Pfizer generated a total of $52.8 billion revenues during 2016. Pfizer reported a revenue growth of 8.1% year-over-year during 2016. The revenues and the revenue growth correspond to the fiscal year ending in December.

Pfizer (PFE) Sales, Marketing, General & Administrative (SG&A) Spending Analysis From 2012 To 2016

This report provides the last five years sales, marketing, general & administrative (SG&A) expenses of Pfizer Inc (PFE) from 2012 to 2016. Pfizer spent a total of $14.8 billion on sales, marketing, general, and administrative (SG&A) activities during 2016. Pfizer generated a total of $52.8 billion revenues during 2016. As a percentage of revenues, Pfizer spent 28.1% of its total revenues on SG&A activities during 2016. The SG&A spending numbers are for the fiscal year ending in December.

Pfizer (PFE) Cost of Sales (COGS) Analysis From 2012 To 2016

This report provides the last five years cost of sales (COGS) analysis of Pfizer Inc (PFE) from 2012 to 2016. Pfizer spent a total of $12.3 billion on COGS during 2016. Pfizer generated a total of $52.8 billion revenues during 2016. As a percentage of revenues, Pfizer spent 23.3% of its total revenues on COGS during 2016. The cost of sales (COGS) numbers are for the fiscal year ending in December.

Pfizer (PFE) Accounts Payable (A/P) Analysis From 2012 To 2016

This report provides the last five years Accounts Payable (A/P) analysis of Pfizer Inc (PFE) from 2012 to 2016. Pfizer invested a total of $6.5 billion on accounts payable during 2016. Pfizer generated a total of $52.8 billion revenues during 2016. As a percentage of revenues, Pfizer invested 12.3% of its total revenues on accounts payable activities during 2016. The accounts payable numbers are for the fiscal year ending in December.

Pfizer (PFE) Accounts Receivable (A/R) Analysis From 2012 To 2016

This report provides the last five years Accounts Receivable (A/R) analysis of Pfizer Inc (PFE) from 2012 to 2016. Pfizer invested a total of $8.2 billion on accounts receivable during 2016. Pfizer generated a total of $52.8 billion revenues during 2016. As a percentage of revenues, Pfizer invested 15.6% of its total revenues on accounts receivable during 2016. The accounts receivable numbers are for the fiscal year ending in December.

Pfizer (PFE) Inventory Spending Analysis From 2012 To 2016

This report provides the last five years inventory spending analysis of Pfizer Inc (PFE) from 2012 to 2016. Pfizer invested a total of $6.8 billion on inventories during 2016. Pfizer generated a total of $52.8 billion revenues during 2016. As a percentage of revenues, Pfizer invested 12.8% of its total revenues on inventories during 2016. The inventory numbers are for the fiscal year ending in December.

Pfizer (PFE) Property, Plant & Equipment (PP&E) Investment Analysis From 2012 To 2016

This report provides the last five years property, plant & equipment (PP&E) investment analysis of Pfizer Inc (PFE) from 2012 to 2016. Pfizer invested a total of $13.3 billion on property, plant & equipment (PP&E) activities during 2016. Pfizer generated a total of $52.8 billion revenues during 2016. As a percentage of revenues, Pfizer invested 25.2% of its total revenues on PP&E activities during 2016. The PP&E investment numbers are for the fiscal year ending in December.